Dr. Shyh-Jeun Wang, MD

Dr. Wang practices at Sunrise Hospital and Medical Center in Las Vegas, Nevada, part of HCA Healthcare.

Dr. Wang's NPI, 1053653709, was assigned on March 20, 2013. Dr. Wang holds Nevada license 16366.

Dr. Wang's primary practice is Sunrise Hospital and Medical Center, at 3186 S Maryland Pkwy, Las Vegas, NV 89109 in Clark County. The practice phone is (702) 731-8000.

Dr. Wang's primary practice is Sunrise Hospital and Medical Center in Las Vegas, Nevada, part of HCA Healthcare. Dr. Wang is also affiliated with Valley Hospital Medical Center. The medical group on file is Platinum Hospitalists. Dmand AI also links Dr. Wang to 1 more hospital, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 6 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Wang is licensed in Nevada.

CMS data shows 846 Medicare services from Dr. Wang across 3 procedure codes in 2024, for 170 Medicare patients. Medicare paid $75,842 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 170 Medicare patients who saw Dr. Wang in 2024. The largest group is 75 to 84, with 73 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 70, with 45% women.

In 2024, Dr. Wang wrote 47 Medicare Part D claims for 15 patients. 94% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $89 in total drug cost. In 2022, CMS named 16 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Wang for performance year 2024, reported as part of a group. Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Wang in 2022. Dr. Wang's most frequent co-authors are Michael Lee, MD and Amy Zhang, MD.

CMS Open Payments shows 10 general payments to Dr. Wang from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $264.